falsified semaglutide Hypoglycaemic coma induced by a product: a case report 🚨 Falsified Ozempic (semaglutide) pens

The HealthRX prescribing team uses a four-factor selection framework when choosing between semaglutide and tirzepatide for a new patient: (1) insurance prior-authorization likelihood based on diagnosis codes and payer type, (2) baseline HbA1c and fasting glucose to determine whether GIP-receptor co-agonism adds glycemic benefit, (3) patient-reported history of nausea with prior GLP-1 exposure, and (4) whether the patient has a documented BMI 30 or a qualifying comorbidity at BMI 27, since that threshold governs Zepbound coverage under most commercial plans

Because of their inherent plasticity, macrophages are capable of integrating a wide array of environmental signals, resulting in a functional spectrum that spans from M1 to M2 phenotypes in vivo ( 19 )

Avoid adding sugar and heavy cream

HDAC inhibitor sodium butyrate-mediated epigenetic regulation enhances neuroprotective function of microglia during ischemic stroke

Ozempic: the SUSTAIN trials Ozempic was studied in the SUSTAIN trial programme, primarily in people with type 2 diabetes